IMUFLEX WB-RP Blood Bag System with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm Anticoagulant Citrate Phosphate Dextrose (CPD) AND OPTISOL (AS-5) Red Cell Preservative
IMUFLEX WB-RP BLOOD BAG SYSTEM with Integral Whole Blood Leukocyte Reduction Filter (Removing Platelets) with Diversion Blood Sampling Arm
Approved
Approval ID
8b22a4c8-2d6e-45d5-82e2-02ef0b713095
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 18, 2019
Manufacturers
FDA
Terumo Corporation
DUNS: 690543319
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code53877-006
Application NumberBN880217
Product Classification
M
Marketing Category
C73594
G
Generic Name
Anticoagulant Citrate Phosphate Dextrose (CPD) AND AS-5 Red Cell Preservative
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateDecember 18, 2019
FDA Product Classification